vida: extract claims from 2025-12-17-weight-watchers-med-plus-glp1-program-2026-no-cgm-integration
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

- Source: inbox/queue/2025-12-17-weight-watchers-med-plus-glp1-program-2026-no-cgm-integration.md
- Domain: health
- Claims: 0, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
This commit is contained in:
Teleo Agents 2026-05-01 04:37:55 +00:00
parent 090f10af17
commit 701c0acff4
2 changed files with 11 additions and 1 deletions

View file

@ -52,3 +52,10 @@ WeightWatchers' post-bankruptcy (May 2025) strategy shows selective CGM deployme
**Source:** Noom press releases + Pharmaceutical Commerce, December 2025
Noom's December 2025 'Proactive Health Microdose GLP-1Rx' program ($149/month) combines microdosed GLP-1 with at-home biomarker testing every four months, representing a distinct atoms-to-bits integration strategy from Omada's continuous CGM monitoring. This periodic biomarker testing approach (quarterly) vs. continuous monitoring (daily) represents two different physical-to-digital integration strategies with different cost/adherence tradeoffs. Noom achieved $100M revenue run-rate within four months of launching GLP-1 programs in September 2024, demonstrating that periodic biomarker testing can be commercially viable as a physical integration layer.
## Supporting Evidence
**Source:** HIT Consultant Dec 2025, WW Clinic review 2026
WeightWatchers Med+ program (launched December 2025, 7 months post-bankruptcy) excludes CGM integration for general obesity/GLP-1 program despite having CGM for diabetes tier. WW chose behavioral depth + prescribing quality over physical data integration. This creates a direct market test: WW (behavioral-only for general obesity) vs Omada (CGM-integrated, profitable 2025 IPO). WW's 21% weight loss claim relies on internal study (n=3,250), not externally validated. The one-time metabolic lab work is a single physical data capture, not continuous monitoring like Omada's CGM.

View file

@ -7,10 +7,13 @@ date: 2025-12-17
domain: health
secondary_domains: []
format: thread
status: unprocessed
status: processed
processed_by: vida
processed_date: 2026-05-01
priority: medium
tags: [WeightWatchers, GLP-1, CGM, atoms-to-bits, Belief4, obesity-management, behavioral-support, telehealth]
intake_tier: research-task
extraction_model: "anthropic/claude-sonnet-4.5"
---
## Content